Co-beneldopa (Benserazide/levodopa) Prescribing at MODALITY PARTNERSHIP (AWC)
Drugs used in parkinsonism and related disorders | Central Nervous System
Items (12m)
1,945
Total Quantity
260.1K
NHS Cost
£18.5K
vs National Avg
+1186.6%
MODALITY PARTNERSHIP (AWC) prescribed 1,945 items of Co-beneldopa (Benserazide/levodopa) over the last 12 months at a cost of £18,477 to the NHS. This is 1186.6% above the national average prescribing rate. Co-beneldopa (Benserazide/levodopa) is classified under Drugs used in parkinsonism and related disorders in the BNF.
Monthly Prescribing Trend
Jun 2026
201
Jun 2026
146
Jun 2026
158
Jun 2026
165
Jun 2026
156
Jun 2026
142
Jun 2026
199
Jun 2026
169
Jun 2026
154
Jun 2026
128
Jun 2026
150
Jun 2026
177
Prescribing Details
| Total Items | 1,945 |
|---|---|
| Total Quantity | 260,100 |
| Total NHS Cost | £18,477 |
| Presentations | 12 different forms |
| vs National Average | +1186.6% |
Co-beneldopa (Benserazide/levodopa) Prescribing Comparison
| This practice | 1,945 items |
|---|---|
| National average per practice | 151 items |
| Difference | +1186.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.